Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Zhang F, Guo W, Zhou B, Wang S, et al. Research article: Three-year Follow-up of Neoadjuvant PD-1 inhibitor (Sintilimab) in Non-Small Cell Lung Cancer. J Thorac Oncol 2022 May 9. pii: S1556-0864(22)00216.
PMID: 35550174


Privacy Policy